Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: CHESS System
Behavioral: Cancer Information Mentor

First Posted Date: 2007-08-15

Last Posted Date: 2018-10-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 209

Registration Number: NCT00516256

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Phase 3

Terminated

Conditions: Breast Cancer
Fatigue
Gastrointestinal Cancer

Interventions: Drug: Methylphenidate
Drug: Placebo

First Posted Date: 2007-08-15

Last Posted Date: 2018-01-03

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 42

Registration Number: NCT00516269

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis

Phase 1

Terminated

Conditions: Neoplastic Meningitis

Interventions: Drug: DepoCyt
Drug: Temozolomide

First Posted Date: 2007-08-14

Last Posted Date: 2012-03-12

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 11

Registration Number: NCT00515788

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Papillary Serous Carcinoma of the Endometrium

Phase 2

Completed

Conditions: Endometrial Cancer

Interventions: Drug: Paclitaxel
Radiation: Pelvic Radiation
Drug: Dexamethasone
Drug: Cimetidine
Drug: Diphenhydramine

First Posted Date: 2007-08-13

Last Posted Date: 2014-07-03

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT00515073

Locations: 🇺🇸
M. D. Anderson Cancer Center - Orlando, Orlando, Florida, United States
🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Psychophysical Studies of Cancer Therapy Pain

Recruiting

Conditions: Advanced Cancer
Pain

Interventions: Other: Sensory Tests

First Posted Date: 2007-08-13

Last Posted Date: 2025-06-10

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 450

Registration Number: NCT00515060

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Depression Treatment and Screening in Ovarian Cancer Patients

Phase 1

Active, not recruiting

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cancer

Interventions: Other: Telephone Counseling
Other: Usual Care

First Posted Date: 2007-08-13

Last Posted Date: 2025-03-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 409

Registration Number: NCT00515372

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Docetaxel
Drug: Carboplatin
Drug: Etoposide
Drug: Cisplatin

First Posted Date: 2007-08-10

Last Posted Date: 2020-09-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 121

Registration Number: NCT00514540

Locations: 🇺🇸
University of California-San Francisco, San Francisco, California, United States
🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines

Phase 1

Terminated

Conditions: Leukemia

Interventions: Biological: Autologous Dendritic Cells

First Posted Date: 2007-08-09

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT00514189

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Curbing Tobacco Use in Suburban and Rural Schools

Phase 1

Completed

Conditions: Tobacco Use Cessation

Interventions: Behavioral: Smoking Prevention Program
Behavioral: Focus Group
Behavioral: Survey

First Posted Date: 2007-08-08

Last Posted Date: 2017-11-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1289

Registration Number: NCT00513097

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

Phase 3

Completed

Conditions: Gastrointestinal Cancer
Lung Cancer

Interventions: Drug: Melatonin
Drug: Placebo

First Posted Date: 2007-08-08

Last Posted Date: 2012-12-11

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 82

Registration Number: NCT00513357

Locations: 🇺🇸
Joan Karnell Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy